ALDH1A2 and Behcet disease: This study identified four drugs with potential therapeutic effects on ALDH1A2 and FZD2, including VANTICTUMAB, RETINOL, HYDROCHLOROTHIAZIDE, and ATENOLOL, which may prove beneficial for treating BD individuals with HF.